Your browser doesn't support javascript.
loading
Effect of sofosbuvir-based treatment on clinical outcomes of patients with COVID-19: a systematic review and meta-analysis of randomised controlled trials.
Hsu, Chi-Kuei; Chen, Ching-Yi; Chen, Wang-Chun; Lai, Chih-Cheng; Hung, Shun-Hsing; Lin, Wei-Ting.
Afiliación
  • Hsu CK; Division of Chest Medicine, Department of Internal Medicine, E-Da Hospital, I-Shou University, Kaohsiung, Taiwan; School of Medicine, College of Medicine, I-Shou University, Kaohsiung, Taiwan; Department of Critical Care Medicine, E-Da Hospital, Kaohsiung, Taiwan.
  • Chen CY; Division of Chest Medicine, Department of Internal Medicine, E-Da Hospital, I-Shou University, Kaohsiung, Taiwan; School of Medicine, College of Medicine, I-Shou University, Kaohsiung, Taiwan.
  • Chen WC; Institute of Biotechnology and Chemical Engineering, I-Shou University, Kaohsiung, Taiwan; Department of Pharmacy, E-Da Hospital, Kaohsiung, Taiwan.
  • Lai CC; Department of Internal Medicine, Kaohsiung Veterans General Hospital, Tainan Branch, Tainan, Taiwan.
  • Hung SH; Division of Urology, Department of Surgery, Chi Mei Hospital, Chia Li, Tainan, Taiwan. Electronic address: e197948@yahoo.com.tw.
  • Lin WT; Department of Orthopedics, Chi Mei Medical Center, Tainan, 71004, Taiwan. Electronic address: aapriliaa@gmail.com.
Int J Antimicrob Agents ; 59(3): 106545, 2022 Mar.
Article en En | MEDLINE | ID: mdl-35134505
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 4_TD Problema de salud: 1_doencas_nao_transmissiveis / 4_covid_19 Asunto principal: Tratamiento Farmacológico de COVID-19 Tipo de estudio: Clinical_trials / Systematic_reviews Límite: Humans Idioma: En Revista: Int J Antimicrob Agents Año: 2022 Tipo del documento: Article País de afiliación: Taiwán
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 4_TD Problema de salud: 1_doencas_nao_transmissiveis / 4_covid_19 Asunto principal: Tratamiento Farmacológico de COVID-19 Tipo de estudio: Clinical_trials / Systematic_reviews Límite: Humans Idioma: En Revista: Int J Antimicrob Agents Año: 2022 Tipo del documento: Article País de afiliación: Taiwán